Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and Dec 2025.
- Largest single sale: $1.9M (19,351 shares) of Rhythm Pharmaceuticals, Inc. on Nov 7, 2025. Filing
- Last sale before this period: Jul 29, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Human Resources Officer | Jul 27, 2021 | Feb 13, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 1, 2026, Rhythm Pharmaceuticals, Inc.: 13,293 shares vested; 4,731 shares withheld by the company for taxes. 1 filing: 1
- Dec 11, 2025, Rhythm Pharmaceuticals, Inc.: sold 3,350 shares for $372K, under a disclosed plan; 3,350 shares acquired by exercising options. 1 filing: 1
- Nov 20, 2025, Rhythm Pharmaceuticals, Inc.: sold 3,350 shares for $352K, under a disclosed plan; 3,350 shares acquired by exercising options. 1 filing: 1
- Nov 10, 2025, Rhythm Pharmaceuticals, Inc.: sold 3,515 shares for $352K, under a disclosed plan; 3,515 shares acquired by exercising options. 1 filing: 1
- Nov 7, 2025, Rhythm Pharmaceuticals, Inc.: sold 19,351 shares for $1.9M, under a disclosed plan; 19,351 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.